S.C. Heslinga
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Systemic Lupus Erythematosus Research
-
- Psoriasis: Treatment and Pathogenesis
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Spondyloarthritis Studies and Treatments 4
- Systemic Lupus Erythematosus Research 3
- Rheumatoid Arthritis Research and Therapies 1
-
- Vasculitis and related conditions 1
- Co-authors
- Michael T. Nurmohamed (4 shared papers)Vokko P. van Halm (3 shared papers)Katalin Boér (1 shared paper)Alper M. van Sijl (1 shared paper)Irene E. van der Horst‐Bruinsma (2 shared papers)Otto Kamp (1 shared paper)Michael W.T. Tanck (1 shared paper)Judy Geissler (1 shared paper)
- Journals
- Arthritis & Rheumatology (1 paper)Annals of the Rheumatic Diseases (1 paper)Heart (1 paper)Current Medicinal Chemistry (1 paper)Rheumatology International (1 paper)
- Partner nations
- NetherlandsUnited States
In The Last Decade
S.C. Heslinga
4 papers receiving 112 citations
Peers
Comparison fields: 5 of 27
- Rheumatology 69
- Immunology 26
- Cardiology and Cardiovascular Medicine 12
- Hematology 5
- Ophthalmology 3
Countries citing papers authored by S.C. Heslinga
This map shows the geographic impact of S.C. Heslinga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.C. Heslinga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.C. Heslinga more than expected).
Fields of papers citing papers by S.C. Heslinga
This network shows the impact of papers produced by S.C. Heslinga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.C. Heslinga. The network helps show where S.C. Heslinga may publish in the future.
Co-authors
The 21 scholars most cited alongside S.C. Heslinga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 81 | |
| 2 | 2015 | 13 | |
| 3 | 2021 | 11 | |
| 4 | 2015 | 9 | |
| 5 | 2016 | 0 |
About S.C. Heslinga
S.C. Heslinga is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Ophthalmology, Infectious Diseases and Organic Chemistry, having authored 5 papers that have together received 114 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (4 papers), Systemic Lupus Erythematosus Research (3 papers), Ocular Diseases and Behçet’s Syndrome (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper) and Vasculitis and related conditions (1 paper). The work is most often cited by research in Rheumatology (69 citations), Immunology (26 citations), Cardiology and Cardiovascular Medicine (12 citations), Hematology (5 citations) and Ophthalmology (3 citations). S.C. Heslinga has collaborated with scholars based in Netherlands and United States. Frequent co-authors include Michael T. Nurmohamed, Vokko P. van Halm, Katalin Boér, Alper M. van Sijl, Irene E. van der Horst‐Bruinsma, Otto Kamp, Michael W.T. Tanck, Judy Geissler, J. Bart A. Crusius and M. Louis Handoko. Their work appears in journals such as Arthritis & Rheumatology, Annals of the Rheumatic Diseases, Heart, Current Medicinal Chemistry and Rheumatology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.